A. Bouville et al., EVALUATING THE RELIABILITY OF BIOKINETIC AND DOSIMETRIC MODELS AND PARAMETERS USED TO ASSESS INDIVIDUAL DOSES FOR RISK ASSESSMENT PURPOSES, Radiation protection dosimetry, 53(1-4), 1994, pp. 211-215
Citations number
NO
Categorie Soggetti
Radiology,Nuclear Medicine & Medical Imaging","Nuclear Sciences & Tecnology
The National Council on Radiation Protection and Measurements (NCRP) i
s in the final stages of preparation of a document discussing the reli
ability of biokinetic and dosimetric models and parameters used to ass
ess individual doses for risk assessment purposes. An effort is made i
n the NCRP document to identify the strengths and weaknesses of the cu
rrently used biokinetic and dosimetric models, to evaluate the main ca
uses of uncertainty associated with important parameters and to show,
by way of examples, how an uncertainty analysis can be carried out. It
is recognised, however, that most of the information available to con
duct a detailed quantitative analysis relates only to a few radionucli
des and that many gaps have to be filled in a subjective manner. As an
exercise, members of the NCRP group were asked to estimate in a subje
ctive manner the reliability of the dose coefficients published in ICR
P Publication 30 for a list of about 20 radionuclides commonly associa
ted with nuclear facilities. For each radionuclide, the chemical form
was specified and two populations were considered: (1) healthy adult m
ales, and (2) special groups expected to receive higher doses per unit
intake than the average. According to the information provided by the
members of the NCRP group, the effective dose received by most health
y males should be within a factor of 10 of the ICRP 30 value for most
radionuclides and within a factor of 20 for special groups. This paper
summarises the main issues that are discussed in the NCRP document wi
th respect to the identification and application of procedures for the
assessment of the reliability of dose coefficients for estimation of
risks to individuals.